Laurus Labs Q3 Results: PAT rises 32% YoY to Rs 203 cr, revenue jumps 50%Laurus Labs said revenue from its Synthesis and active pharmaceutical ingredients (API) businesses, each of which account for more than 40%...
3 reasons Laurus Labs is this week's stock pickLaurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 v...
MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 35388.93 Crore) operating in Pharmaceutica...
Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 36448.72 Crore) operating in Pharmaceutica...
Buy Laurus Labs, target price Rs 615: Motilal OswalThe brokerage expects a 23 per cent earnings CAGR, led by a 22 per cent sales CAGR in the FDF/other API segment and a 31 per cent sales CAG...
Bajaj Healthcare gets Gujarat FDA nod to manufacture hydhroxychloroquine sulphateThe company will commence production of hydhroxychloroquine sulphate API in the next 3 weeks at its Vadodara facility and it is estimated t...
India to get Swiss bank details of all Indians from Sept; accounts closed in 2018 also includedSwitzerland will share account numbers, credit balance and other info with India by September this year.
Black Money: Swiss start consultations on automatic exchange of info with IndiaSwitzerland today initiated its statutory consultation process for bringing into force Automatic Exchange of Information (AEOI) on tax matt...
Significant progress in tax cooperation with India: Swiss governmentMaurer had said the country's cooperation on tax matters with India in terms of sharing information on suspected black money cases would co...
Safe-deposit boxes prone to money-laundering risks: Swiss governmentSafe-deposit boxes used in Switzerland are prone to risk of money laundering and terror financing activities, but existing regulations are ...
Nepal President Ram Baran Yadav asks PM to open talks with minority partiesYadav today asked PM Sushil Koirala to open talks with the agitating minority parties who are sticking to their demand for amendment of the...
FDA hikes fee for drug approvals, cuts unit inspection chargeUS regulator FDA has hiked its fees for new generic drug applications by up to 30 per cent, a move that may hit hard Indian drugmakers.
Indian drugmakers to pay higher facility fees on US hikeThe new rates, applicable on companies from all nations, are effective from Oct 1 and will remain in force through Sept 30, 2015, as per FD...
US generic drug fee relief plan may benefit Indian companiesAmerican health regulator FDA could consider bringing some relief in payment of fees to small generic drug makers, including those from Ind...
US to hike fees for generic drugmakers; Indian firms to be hitUS health regulator FDA is hiking the fees for generic drugmakers by up to 48 per cent from October, that will hit Indian drugmakers.
Illicit wealth under corporate veil maximum in US: SwitzerlandSwitzerland has claimed that the maximum instances of "corrupt assets" being concealed under corporate veil have been found in US and the E...